Actoplus met
Actoplus met is a diabetes medication containing Metformin + Pioglitazone, available as 500/15mg tablets.
- Category
- Diabetes
- Active ingredient
- Metformin · Pioglitazone
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 500/15mg
Prescription rules on Actoplus met vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Therapeutic Class
- Biguanide, Thiazolidinedione
- Pharmacological Class
- Biguanide, Thiazolidinedione
- Minor Side Effects
- nausea, diarrhoea
- Moderate Side Effects
- peripheral oedema, weight gain
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- Takeda Pharmaceutical
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage Instructions
- Store below 25°C.
- Drug Interactions
- alcohol, iodinated contrast agents
- Age Restrictions
- Adult use only.